Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Paula J. Lum"'
Autor:
Snehal S. Lopes, Irene Pericot-Valverde, Paula J. Lum, Lynn E. Taylor, Shruti H. Mehta, Judith I. Tsui, Judith Feinberg, Arthur Y. Kim, Brianna L. Norton, Kimberly Page, Cristina Murray-Krezan, Jessica Anderson, Alison Karasz, Julia Arnsten, Phillip Moschella, Moonseong Heo, Alain H. Litwin
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Self-reported adherence to direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV) among persons who inject drugs (PWID) is often an overreport of objectively measured adherence. The association of such overreporting with
Externí odkaz:
https://doaj.org/article/9c336d8dbf30498a87f9f33fc5063a19
Autor:
Snehal S. Lopes, Moonseong Heo, Irene Pericot-Valverde, Brianna L. Norton, Lynn E. Taylor, Judith I. Tsui, Shruti H. Mehta, Judith Feinberg, Arthur Y. Kim, Paula J. Lum, Kimberly Page, Cristina Murray-Krezan, Jessica Anderson, Alain H. Litwin, the HERO Study Group
Publikováno v:
Viruses, Vol 16, Iss 10, p 1551 (2024)
Heterogeneity of outcomes across different clinical trial study sites is often inevitable. Understanding how outcomes differ by site is important for planning future programs and studies. We examined the extent of heterogeneity of hepatitis C virus (
Externí odkaz:
https://doaj.org/article/7e4b84b93e814b6594ec80763df7e804
Autor:
Kim A. Hoffman, Robin Baker, Laura C. Fanucchi, Paula J. Lum, Lynn E. Kunkel, Javier Ponce Terashima, Dennis McCarty, Petra Jacobs, P. Todd Korthuis
Publikováno v:
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-usual (i.e., buprenorp
Externí odkaz:
https://doaj.org/article/2f820b33cf314209a1db427de7bc6add
Autor:
Kim A. Hoffman, Robin Baker, Lynn E. Kunkel, Elizabeth Needham Waddell, Paula J. Lum, Dennis McCarty, P. Todd Korthuis
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background The CTN-0067 CHOICES trial tests implementation of extended-release naltrexone (XR-NTX) versus treatment-as-usual (TAU) for opioid use disorders (OUD) in HIV clinics to improve HIV viral suppression. The study team investigated re
Externí odkaz:
https://doaj.org/article/322f0736011f4768bbe2727affd9fa44
Publikováno v:
Addiction Science & Clinical Practice, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a low barrier buprenorphi
Externí odkaz:
https://doaj.org/article/896463858fb64bb2ac038b567b80f03c
Autor:
Jennifer E. Hettema, Stephanie A. Cockrell, Abigail Reeves, Karen S. Ingersoll, Paula J. Lum, Richard Saitz, Cristina M. Murray-Krezan, Valerie A. Carrejo
Publikováno v:
Addiction Science & Clinical Practice, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background While brief intervention (BI) for risky alcohol use generally yields positive effects among those identified by screening, effect sizes are small and there is unexplained heterogeneity in outcome. The heterogeneity may be related
Externí odkaz:
https://doaj.org/article/62520f83493d4decb93595ab004ba193
Autor:
Carol Dawson-Rose, Jessica E. Draughon, Yvette Cuca, Roland Zepf, Emily Huang, Bruce A. Cooper, Paula J. Lum
Publikováno v:
Addiction Science & Clinical Practice, Vol 12, Iss 1, Pp 1-11 (2017)
Abstract Background Substance use is common among people living with HIV (PLHIV) and is associated with worse outcomes along the HIV care continuum. One potentially effective clinic-based approach to addressing unhealthy substance use is screening, b
Externí odkaz:
https://doaj.org/article/b9eafb9e438841ec94cee24ff45fd518
Autor:
Alain H Litwin, Paula J Lum, Lynn E Taylor, Shruti H Mehta, Judith I Tsui, Judith Feinberg, Arthur Y Kim, Brianna L Norton, Moonseong Heo, Julia Arnsten, Paul Meissner, Alison Karasz, M Diane Mckee, John W Ward, Nirah Johnson, Irene Pericot-Valverde, Linda Agyemang, Ellen S Stein, Aurielle Thomas, Courtney Borsuk, Kendra L Blalock, Samuel Wilkinson, Katherine Wagner, Jillian Roche, Cristina Murray-Krezan, Jessica Anderson, Vanessa Jacobsohn, Anne F Luetkemeyer, Oluwaseun Falade-Nwulia, Kimberly Page
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:1112-1127
To achieve WHO targets for the elimination of hepatitis C virus (HCV) as a public threat, an increased uptake of HCV treatment among people who inject drugs (PWID) is urgently needed. Optimal HCV co-located treatment models for PWID have not yet been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc06dee0f6dc1bc2b8c4b4e2fa24c53
https://doi.org/10.1016/s2468-1253(22)00275-8
https://doi.org/10.1016/s2468-1253(22)00275-8
Autor:
Hong-Ha M. Truong, Melissa R. Krone, Peter W. Hunt, Jeffrey N. Martin, Robin Fatch, Paula J. Lum, Steven G. Deeks
Publikováno v:
Current HIV Research. 19:497-503
Background: Antiretroviral therapy (ART) non-adherence and methamphetamine use are associated with higher HIV drug resistance prevalence. How they affect drug resistance mutations accumulation is less studied. Objective: We assessed factors associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2089f56b34931cdb51517861094cab5
https://doi.org/10.2174/1570162x19666210625103902
https://doi.org/10.2174/1570162x19666210625103902
Autor:
Judith I. Tsui, Paula J. Lum, Lynn E. Taylor, Shruti H. Mehta, Judith Feinberg, Arthur Y. Kim, Brianna L. Norton, Jiajing Niu, Moonseong Heo, Julia Arnsten, Irene Pericot-Valverde, Aurielle Thomas, Kendra L. Blalock, Andrea Radick, Cristina Murray-Krezan, Kimberly Page, Alain H. Litwin
Publikováno v:
Drug and Alcohol Dependence. 247:109878
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::903719ed5a261065e31a303842f1d647
https://doi.org/10.1016/j.drugalcdep.2023.109878
https://doi.org/10.1016/j.drugalcdep.2023.109878